European Society for Cardiovascular and Endovascular Surgery

Tweet this page
<
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 17 May 2018
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

37,500€

Financial year: Jan 2017 - Dec 2017

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    European Society for Cardiovascular and Endovascular Surgery   (ESCVS)

    EU Transparency Register

    806557131478-97 First registered on 08 May 2018

    Goals / Remit

    CONSTITUTION

    Article 1
    GENERAL PROVISIONS

    Section 1
    1. The name of the organisation shall be European Society for Cardiovascular and Endovascular Surgery (ESCVS), hereinafter referred to as the Society or ESCVS.
    2. The registered office of the Society shall be Schlossbergstrasse 12, 8802 Kilchberg, Zürich.
    3. The Society is an entity with legal personality acting in compliance with Article 60 et seq. of the Swiss civil code.

    Section 2
    1. The Society shall act within Switzerland and worldwide and in performing its statutory objective the Society may also act within the boundaries of other countries, respecting the local laws.
    2. The Society may open its country branches.
    3. The Society may cooperate with similar national and international organisations and may be their member.
    4. The Society may conduct economic activity. The ensuing profit shall be used towards the fulfilment of its statutory objective and may not be divided between its members.
    5. The activity of the Society is based on its members’ volunteer work. The Society may have employees or may commission other individuals or entities to perform certain tasks.

    Section 3
    1. The Society may use badges and stamps in compliance with relevant regulations.
    2. The official language of the meetings of the Society shall be English, with the exception of documents required by law to be drawn up in the German language.
    Article 2
    THE OBJECTIVE OF THE SOCIETY AND ITS FULFILMENT

    Section 4
    The objective of the Society is to:
    1) promote medical scientific and clinical research, with special emphasis on cardiovascular diseases;
    2) monitor the development of the medical art, science and therapy of cardiovascular diseases;
    3) coordinate and disseminate the theoretical and practical medical knowledge, with special emphasis on cardiovascular diseases;
    4) facilitate the exchange of ideas in the field of cardiovascular diseases, particularly through scientific meetings and personal contact between cardiac and vascular specialists;
    5) be constantly concerned for the level of physicians’ and other medical staff’s education;
    6) promote new, innovative treatments.






    Section 5
    The Society shall fulfil its objective through:
    1) public speaking and expressing its stance;
    2) organising conferences, workshops, scientific meetings, and especially the annual International ESCVS Congress;
    3) conducting advisory and informative activity;
    4) organising competitions and granting awards for outstanding work in the field of cardiovascular diseases;
    5) conducting editorial activity in the form of guidelines, position statements, recommendations in modern cardiac, vascular and endovascular surgery and medicine as well as other journals, brochures, books and other scientific and informative materials, within its own resources or by commissioning specialized entities;
    6) organising national meetings, workshops and teaching sessions related to cardiovascular disease diagnostic and therapies for physicians in training (residents) and specialists during annual ESCVS Congresses;
    7) undertaking other actions conducive to the fulfilment of the statutory objective of the Society.

    Main EU files targeted

    Joint meeting at 22nd of May 2018, of European Leaders in Cardiovascular Medicine of EACTS, ESC, and ESCVS with VYTENIS ANDRIUKAITIS, HIGH EU COMMISSIONER FOR HEALTH AND FOOD SAFETY AND ANDRZEJ RYS, DIRECTOR FOR HEALTH SYSTEMS AND MEDICAL PRODUCTS AND INNOVATION

    Address

    Head Office
    Kanzlei Bonin & Uffer
    Bonin Uffer Rechtsanwälte
    Zürich 8008
    SWITZERLAND
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Matthias Thielmann, Prof. Dr. med. (Generalsekretär / Secretary General)

    Person with legal responsibility

    Mr Matthias Thielmann, Prof. Dr. med. (Generalsekretär / Secretary General)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Other organisations

  • Networking

    Affiliation

    ESCVS MEMBERS:
    Members of the ESCVS are physicians, cardiac surgeons, vascular surgeons, physician assistants, nurses, and perfusionists from all over Europe and also from other Non-European countries.

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2017 - Dec 2017

    Lobbying costs for closed financial year

    37,500€

    EU grant income for closed financial year

    20,000 € (Source: HORIZON)

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    JOINT MEETING OF EUROPEAN LEADERS IN CARDIOVASCULAR MEDICINE OF EACTS, ESC AND ESCVS WITH
    VYTENIS ANDRIUKAITIS, HIGH EU COMMISSIONER FOR HEALTH AND FOOD SAFETY
    AND
    ANDRZEJ RYS, DIRECTOR FOR HEALTH SYSTEMS AND MEDICAL PRODUCTS AND INNOVATION

    Date: 22 May 2018
    Time: 9:00 – 11:30
    Location: Brussels, Berlaymont building

    1. Strengthening the role of the European medical registries: recognition and support of registries as useful tools to monitor the availability and effectiveness of treatment (medical, economic) as well as valuable sources of scientific and clinical data for cardiovascular guidelines.

    Presenter:
    EACTS – D. Pagano (15’)
    Comments:
    ESC – P. Kearney (10’)
    ESCVS – M. Thielmann (10’)

    2. The importance and value of multicentre, European, non-commercial scientific and clinical research, its role in the further development of modern evidence-based European cardiovascular medicine. Opportunities and support of EU Commission in conducting and funding such research, cooperation of the ESC/ EACTS/ ESCVS with EU Commission in this matter.

    Presenter:
    ESCVS – N. Bonaros (15’)
    Comments:
    ESC – P. Kirchhof (10’)
    EACTS – M. Zembala (10’)

    3. Prevention in cardiovascular medicine.
    Presenter:
    ESC – P. Kearney (15’)
    Comments:
    EACTS – P. Rajesh (10')
    ESCVS – T. Folliquet (10')

    4. DISCUSSION (30’)

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard